EnVVeno Medical shares surge 11.15% intraday as CEO to participate in live virtual investor session.

enVVeno Medical surged 11.15% intraday following the announcement that its CEO, Robert Berman, will participate in a Live Virtual Investor event. The move likely reflects renewed investor confidence in the company’s strategic communication efforts, as executive engagement in such forums often signals transparency or potential business developments. While the event itself does not detail new products or financial results, the direct involvement of senior leadership typically draws market attention, aligning with the stock’s upward trajectory during regular trading.